After more than three billion doses, the Oxford-AstraZeneca Covid vaccine is being withdrawn. AstraZeneca said it was "incredibly proud" of the vaccine, but it had made a commercial decision.
AstraZeneca said it was "incredibly proud" of the vaccine, but it had made a commercial decision. It said the rise of new coronavirus variants meant demand had shifted to the newer updated vaccines.
The firm's application to withdraw the vaccine was made on ... The Serum Institute of India (SII), which produced AstraZeneca's COVID-19 vaccine under the brand name Covishield, stopped ...
The new development follows the company’s voluntary withdrawal of marketing authorisation for the vaccine in the European Union. Credit: rarrarorro / Shutterstock.com. AstraZeneca has begun the global ...
AstraZeneca has begun the global withdrawal of its Covid-19 vaccine, Vaxzevria, citing a surplus of updated vaccines designed to combat new virus variants. The European Medicines Agency (EMA ...
Drugmaker AstraZeneca is reportedly pulling its COVID-19 vaccine from global markets due to a surplus of updated alternatives ... AstraZeneca said in a statement to CNN that it is working with ...
The pharmaceutical giant AstraZeneca on Tuesday said it is withdrawing its COVID-19 ... would proceed to withdraw Vaxzevria's marketing authorizations within Europe. The vaccine was never approved ...
The Oxford-AstraZeneca Covid vaccine is being withdrawn worldwide ... The application to withdraw the vaccine was made on March 5 and came into effect on Tuesday. Similar applications will ...
AstraZeneca admitted in court documents that its Covid-19 vaccine can lead to ... The application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the ...
Social media posts falsely claim AstraZeneca admitted rare blood clot risk in court documents. Learn the truth about the ...